OraSure Technologies Inc. today announced its OraQuick In-Home HIV Test is available at more than 30,000 retailers nationwide and online at the company’s website.
The release makes the product the first rapid infectious disease test ever to be made available directly to consumers for in-home use.
“For the first time ever, individuals now have access to an in-home rapid oral HIV test-the same test healthcare professionals have used and trusted for years-that will empower them to learn their HIV status in the comfort and privacy of their own home,” said Douglas A. Michels, president and CEO of OraSure Technologies. “This is a tremendous breakthrough in our fight against HIV and AIDS.”
The company is collaborating with a high-profile celebrity, who has yet to be announced, to mark the launch.
The OraQuick In-Home HIV Test detects antibodies to both HIV-1 and HIV-2 with an oral swab, providing a confidential in-home testing option with results in as little as 20 minutes.
The product, Michels said, has been in development since 2005 and received FDA approval on July 3.
“There is still a very large number of Americans infected with HIV and who are unaware of their status, and (the test) provides another opportunity for people to get tested and know their HIV status,” he said.
As of today, the product will be available at neighborhood drug stores such as CVS and Walgreens.
“Our hope is to make a big impact on reducing the stigma associated with HIV and encourage more HIV testing part of a routine for anyone who’s sexually active,” said Michels.
The in-home test is an over-the-counter version of OraQuick ADVANCE, an oral swab rapid test with more than 25 million units sold in the professional market, including doctors, hospitals, clinics and other trained professionals.
To ensure optimal support for individuals using the OraQuick In-Home HIV Test, OraSure is making specialized resources available including live support and comprehensive referral services 24 hours a day, seven days a week, every day of the year, through a toll-free support center and comprehensive consumer website.
Michels said the company hopes to offer the product on a global level in the next two to three years. “Certainly in the next few years, we expect to expand this product internationally in a very significant way,” he said.
The company also hopes to launch a similar in-home test for hepatitis C in the near future.